What Researchers Did
Researchers conducted a retrospective case series involving five COVID-19 patients who received hyperbaric oxygen therapy (HBOT).
What They Found
All five patients presented with tachypnoea and low oxygen saturation despite receiving high oxygen flow. Notably, all five patients recovered without requiring mechanical ventilation.
What This Means for Canadian Patients
This small case series suggests that hyperbaric oxygen therapy might be a potential intervention to explore for Canadian COVID-19 patients experiencing severe respiratory distress. However, due to the very limited number of patients, larger, well-designed studies are needed before any practical recommendations can be made for its widespread use.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
The primary limitation of this study is its very small sample size (n=5) and retrospective case series design, which prevents drawing definitive conclusions about HBOT's efficacy.